• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

BMS-961955

CAS No. 1431328-92-5

BMS-961955 ( BMS961955 )

产品货号. M11828 CAS No. 1431328-92-5

BMS-961955 is an potent, allosteric inhibitor of HCV NS5B polymerase with EC50 of 7.9/4.3 nM for GT 1b/1a replicon respectively.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥15957 有现货
50MG ¥32238 有现货
100MG ¥44550 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    BMS-961955
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    BMS-961955 is an potent, allosteric inhibitor of HCV NS5B polymerase with EC50 of 7.9/4.3 nM for GT 1b/1a replicon respectively.
  • 产品描述
    BMS-961955 is an potent, allosteric inhibitor of HCV NS5B polymerase with EC50 of 7.9/4.3 nM for GT 1b/1a replicon respectively; shows weak activity against PXR; displayes significantly enhanced metabolic stability in CLM and HLM.
  • 同义词
    BMS961955
  • 通路
    Microbiology/Virology
  • 靶点
    HCV
  • 受体
    HCV
  • 研究领域
    Infection
  • 适应症
    ——

化学信息

  • CAS Number
    1431328-92-5
  • 分子量
    658.83
  • 分子式
    C37H43FN4O4S
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    CC1(CC1)S(=O)(=O)NC(=O)C2=CC3=C(C=C2)C(=C4N3CC5(CC5C6=C4C=CC(=C6)F)C(=O)N7C8CCC7CN(C8)C)C9CCCCC9
  • 化学全称
    (4bS,5aR)-12-Cyclohexyl-3-fluoro-4b,5,5a,6-tetrahydro-N-[(1-methylcyclopropyl)sulfonyl]-5a-[(3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl]cycloprop[d]indolo[2,1-a][2]benzazepine-9-carboxamide

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Zheng BZ, et al. Bioorg Med Chem Lett. 2017 Jun 11. pii: S0960-894X(17)30626-1.
产品手册
关联产品
  • Velpatasvir

    Velpatasvir (GS-5816) is a second generation, pan-genotypic inhibitor of HCV NS5A, demonstrates a high barrier to resistance in HCV replicon assays.

  • U18666A

    U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus.

  • Uprifosbuvir

    A novel uridine nucleotide analog HCV NS5B polymerase inhibitor for treatment of HCV infection combined with Grazoprevir and Ruzasvir.